The results of the current study showed that orlistat reduced the expression of Bcl-xL in tumor tissues of HFD, LFD, and HFD-LFD mice, suggesting that orlistat can induce apoptosis in vivo after four weeks of treatment. Here, BCL2L1 is linked to neoplasm.